Correction to: Neuropsychopharmacology https://doi.org/10.1038/s41386-018-0150-5, published online 13 July 2018
In this article, Dr. Gary J. Bassell (gary.bassell@emory.edu) has been added as corresponding author in the web version of this article. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Gross, C., Banerjee, A., Tiwari, D. et al. Correction to: Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model. Neuropsychopharmacol. 47, 1733 (2022). https://doi.org/10.1038/s41386-022-01345-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41386-022-01345-x
